Mattias Andersson
Talks (0)
Bayer wins FDA breakthrough therapy designation for NSCLC candidate - Pharmaceutical Technology
FDA Law Blog
An industry perspective on current QSP trends in drug development | Journal of Pharmacokinetics and Pharmacodynamics
Employment – The Down East Partnership for Children
Senior Director, Patents Audio
Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption | Oncogene
The cost of companion diagnostics in oncology
Acrylamide Questions and Answers | FDA
Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices | FDA
Artificial Intelligence and Machine Learning (AI/ML) for Drug Development | FDA
Pitches (0)
add
Panels (7)
Mattias Andersson

Add at least 3 tags
Your tags